By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Swedish Orphan Biovitrum 


  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a



Company News
Swedish Orphan Biovitrum Receives Orphan Drug Designation For Elocta In Switzerland 4/14/2015 9:30:46 AM
Swedish Orphan Biovitrum's Xiapex Receives Positive Opinion By CHMP For The Treatment Of Peyronie's Disease 12/22/2014 12:54:20 PM
Swedish Orphan Biovitrum Awarded Company Of The Year At The European Mediscience Awards 2014 7/1/2014 9:27:19 AM
Swedish Orphan Biovitrum Establishes North American Office In Massachusetts 6/5/2014 9:33:21 AM
Auxilium Pharmaceuticals (AUXL) And Swedish Orphan Biovitrum Announce Encore Presentation Of XIAFLEX/Xiapex Data At European Association Of Urology Congress 4/14/2014 6:14:09 AM
Swedish Orphan Biovitrum Release: Kiobrina Pivotal Phase 3 Study Did Not Meet Primary Endpoint 3/26/2014 9:29:05 AM
Biogen Idec, Inc. (Massachusetts) (BIIB) And Swedish Orphan Biovitrum Release: New Phase 3 Data Confirm Long-Lasting Characteristics Of ALPROLIX™ And ELOCTATE™ Across Multiple Hemophilia Populations 12/9/2013 9:51:53 AM
Swedish Orphan Biovitrum's Partner Biogen Idec, Inc. (Massachusetts) (BIIB) To Present Phase 3 Data On Prolonged Half-Life Of Hemophilia Candidates In Young Children At Annual American Society of Hematology Meeting 12/3/2013 9:22:09 AM
New Number Of Shares And Votes In Swedish Orphan Biovitrum 12/2/2013 9:40:45 AM
Swedish Orphan Biovitrum Receives Positive CHMP Opinion for Kineret® for Treatment of Rare Disease CAPS 9/23/2013 9:20:38 AM